Biopharmaceutical Manufacturing · Completed 2025

Novartis Biopharmaceutical Production Building

Statutory and BIM coordination for advanced manufacturing.

Client Exyte

Biopharmaceutical ManufacturingProduction BuildingBIM CoordinationAuthority SubmissionsQualified Person

Aerial view of the completed Novartis biopharmaceutical production building in Singapore

Project story

Capability in context.

Part of Novartis's US$256 million expansion of its Singapore biopharmaceutical manufacturing site, the new production building strengthens capacity for therapeutic antibody medicines.

Its completed exterior brings together robust industrial envelopes, elevated process links and tightly coordinated utility infrastructure within a highly digitalised manufacturing campus.

VivATA’s role

Appointed Qualified Person for authority submissions, including BIM coordination, supporting statutory coordination and approvals for this biopharmaceutical manufacturing project.

Completed metal-clad Novartis production building and sheltered connection

Street-corner view of the Novartis production building's metal-clad exterior

Long external elevation of the completed Novartis production building

Production building corner viewed along the completed service road

External process link connecting the Novartis production buildings

External process infrastructure beside the Novartis production building

Wide external view of the process yard and production infrastructure

Novartis production facility and process infrastructure viewed across the landscape

Explore more work

Novartis Biopharmaceutical Production Building

Capability in context.

Related project stories.

Meranti Power OCGT Facility

Huber’s Butchery at Dempsey

NTU Joint Laboratory